Company & Sponsor Intelligence
Mundipharma Research GmbH & Co KG
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials1
Recruiting0
Completed1
Countries1
Therapeutic footprint
parkinsons
Indexed studies
NCT01439100A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain
parkinsons · CzechiaPHASE3
parkinsons · CzechiaPHASE3
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →